RetinalGenix Technologies Inc. SEC filings RTGN

RetinalGenix Technologies Inc. has 114 filings in SEC EDGAR's recent list, going back to Feb 16, 2021. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (auditor change). The company's fiscal year ends on December 31.

Form Description Filed Period
8-K Current report
Auditor change
 Jul 15, 2026 Jul 13, 2026
8-K Current report
Officer or director change
 Mar 26, 2026 Mar 22, 2026
8-K Current report
Material agreement
 Feb 20, 2025 Feb 19, 2025
8-K Current report
Other events
 Apr 8, 2024 Apr 2, 2024
8-K Current report
Officer or director change
 Dec 6, 2023 Dec 4, 2023
8-K Current report
Officer or director change, Other events
 Dec 4, 2023 Nov 30, 2023
8-K Current report
Officer or director change
 Jul 28, 2022 Jul 25, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
 Jul 7, 2022 Jul 5, 2022
8-K Current report
Material agreement
 Feb 17, 2022 Feb 14, 2022
8-K Current report
Material agreement, Unregistered share sale
 Dec 30, 2021 Dec 27, 2021

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
RTGN (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Petaluma, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1836295

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.